G1 Therapeutics Inc (GTHX)

Overview News Price History Option Chain Financials Why GTHX Down? Discussions Forecast

Why is G1 Therapeutics Inc (GTHX) Stock down?

We've noticed a 6.77% decline in G1 Therapeutics Inc (GTHX) stock during the 2024-04-29 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!

13 Dec, 2023:

Shares of G1 Therapeutics Inc (GTHX) dropped by 35.39% from $3.73 to $2.41 in the trading on Wednesday, December 13, 2023. The reason why GTHX down today is due to a lower-than-expected preliminary results from their ongoing Phase 3 trial evaluating trilacilib in metastatic triple-negative breast cancer. The results showed that triacilb did not meet the primary endpoint of improving overall survival. In addition, an analyst from Needham reinterated Buy rating but cautioned that risks remain until the final analysis is available.